A detailed history of Acadian Asset Management LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,566 shares of NPCE stock, worth $38,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,566
Previous 68,918 94.83%
Holding current value
$38,691
Previous $520,000 95.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$6.65 - $8.46 $434,590 - $552,877
-65,352 Reduced 94.83%
3,566 $24,000
Q2 2024

Aug 06, 2024

BUY
$6.38 - $15.33 $138,465 - $332,706
21,703 Added 45.97%
68,918 $520,000
Q1 2024

May 10, 2024

BUY
$9.78 - $17.5 $461,762 - $826,262
47,215 New
47,215 $621,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $270M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.